🔎 Trials Near Me

Почетна › Рак простате › Minesota

Kliničke studije za Рак простате u državi Minesota

47 studija za Рак простате traži učesnike na lokacijama u državi Minesota.

Gradovi u državi Minesota

Zvanični tekst studije (na engleskom)

Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging

  • Minnesota Oncology - Burnsville, Burnsville
  • Minnesota Oncology Hematology PA-Chaska, Chaska
  • Mercy Hospital, Coon Rapids
  • и још 21
Тражи се учесникФаза 3
Узраст 18 и старији · Мушкарци · Ажурирано 13. 11. 2026. · NCT04423211

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

  • Essentia Health - Deer River Clinic, Deer River
  • Essentia Health Cancer Center, Duluth
  • Fairview Southdale Hospital, Edina
  • и још 9
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT03866382

Sacral Neuromodulation for Male Overactive Bladder (MOAB)

  • Mayo Clinic, Rochester
Тражи се учесник
Узраст 18 и старији · Мушкарци · Ажурирано 12. 11. 2026. · NCT06511141

The Vanguard Study: Testing a New Way to Screen for Cancer

  • Minneapolis VA Medical Center, Minneapolis
Тражи се учесникЗдраве особе су добродошле
Узраст од 45 до 75 · Оба пола · Ажурирано 6. 11. 2026. · NCT06995898

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • Riverwood Healthcare Center, Aitkin
  • Mayo Clinic Health System in Albert Lea, Albert Lea
  • Essentia Health - Baxter Clinic, Baxter
  • и још 49
Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
Узраст од 40 до 75 · Оба пола · Ажурирано 4. 11. 2026. · NCT05334069

Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial

  • Essentia Health Saint Joseph's Medical Center, Brainerd
  • Essentia Health Cancer Center, Duluth
  • Coborn Cancer Center at Saint Cloud Hospital, Saint Cloud
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 3. 11. 2026. · NCT06632977

A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer

  • University Of Minnesota, Minneapolis
Тражи се учесникФаза 1
Узраст 18 и старији · Мушкарци · Ажурирано 3. 11. 2026. · NCT06095089

Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial

  • Coborn Cancer Center at Saint Cloud Hospital, Saint Cloud
  • United Hospital, Saint Paul
Тражи се учесникФаза 3
Узраст 18 и старији · Мушкарци · Ажурирано 3. 11. 2026. · NCT07200830

Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial

  • Sanford Joe Lueken Cancer Center, Bemidji
  • Coborn Cancer Center at Saint Cloud Hospital, Saint Cloud
Тражи се учесникФаза 3
Узраст 18 и старији · Мушкарци · Ажурирано 3. 11. 2026. · NCT06931340

Evaluating Prostate Cancer Patient Natural Killer Cell Function Across Racial Background and Addressing Functional Disparities With Trispecific Killer Engagers

  • University of Minnesota/Masonic Cancer Center, Minneapolis
Тражи се учесникОпсервациона студија
Узраст 18 и старији · Мушкарци · Ажурирано 2. 11. 2026. · NCT07910019

A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)

  • Mayo Clinic in Rochester, Minnesota-Mayo Clinic Comprehensive Cancer Center ( Site 0078), Rochester
  • HealthPartners Cancer Research Center-HealthPartners Frauenshuh Cancer Center ( Site 0032), Saint Louis Park
  • HealthPartners Cancer Center at Regions Hospital ( Site 0052), Saint Paul
Тражи се учесникФаза 3
Узраст 18 и старији · Мушкарци · Ажурирано 30. 10. 2026. · NCT06925737

Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)

  • University of Minnesota Medical Center, Minneapolis
  • Mayo Clinic, Rochester
Тражи се учесникФаза 1
Узраст од 18 до 100 · Мушкарци · Ажурирано 29. 10. 2026. · NCT05519449

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

  • Health Partners Frauenshuh Cancer Center, Saint Louis Park
  • Health Partners Cancer Center at Regions Hospital, Saint Paul
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 26. 10. 2026. · NCT06172478

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

  • Sanford Joe Lueken Cancer Center, Bemidji
  • Essentia Health Saint Joseph's Medical Center, Brainerd
  • Minnesota Oncology Hematology PA-Chaska, Chaska
  • и још 16
Тражи се учесникФаза 3
Узраст 18 и старији · Мушкарци · Ажурирано 23. 10. 2026. · NCT05946213

A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors

  • Research Site 121, Saint Paul
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 21. 10. 2026. · NCT05914116

A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)

  • Mayo Clinic, Rochester
Тражи се учесникФаза 1
Узраст 18 и старији · Мушкарци · Ажурирано 20. 10. 2026. · NCT07103018

A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)

  • Avera Cancer Institute - Marshall ( Site 0122), Marshall
  • HealthPartners Cancer Research Center-HealthPartners Frauenshuh Cancer Center ( Site 0072), Saint Louis Park
  • HealthPartners Cancer Research Center-HealthPartners Cancer Center at Regions Hospital ( Site 0092), Saint Paul
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 20. 10. 2026. · NCT06136650

A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer

  • Minnesota Oncology Hematology PA, Minneapolis
  • University of Minnesota Medical Center Fairview, Minneapolis
Тражи се учесникФаза 3
Узраст 18 и старији · Мушкарци · Ажурирано 20. 10. 2026. · NCT07213674

A Phase I Study of [225Ac]-AZD2284 in Patients With Metastatic Castration-Resistant Prostate Cancer

  • Research Site, Rochester
Тражи се учесникФаза 1
Узраст 18 и старији · Мушкарци · Ажурирано 16. 10. 2026. · NCT06879041

Saruparib in Combination With Physician's Choice of ARPI in Patients With mHSPC Previously Treated With Docetaxel or 177Lu-PSMA Therapy Without Disease Progression and PSA ≥ 0.2 ng/mL (EvoPAR-PR05)

  • Research Site, Marshall
Тражи се учесникФаза 3
Узраст 18 и старији · Мушкарци · Ажурирано 15. 10. 2026. · NCT07711002

Phase Ib/II Platform Study of Multiple Anti-Cancer Agents in Participants With Metastatic Prostate Cancer

  • Research Site, Minneapolis
Тражи се учесникФаза 1/2
Узраст од 18 до 99 · Мушкарци · Ажурирано 14. 10. 2026. · NCT07590934

A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation

  • Research Site, Rochester
Тражи се учесникФаза 3
Узраст 18 и старији · Мушкарци · Ажурирано 14. 10. 2026. · NCT06952803

Adaptive Radiation Therapy (ART) Stereotactic Ablative Body Radiotherapy (SABR) for Primary Localized Prostate Cancer

  • Mayo Clinic Health System in Albert Lea, Albert Lea
  • Mayo Clinic Health System-Mankato, Mankato
  • Mayo Clinic in Rochester, Rochester
Тражи се учесник
Узраст 18 и старији · Мушкарци · Ажурирано 14. 10. 2026. · NCT06325046

Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

  • Mercy Hospital, Coon Rapids
  • Fairview Southdale Hospital, Edina
  • Unity Hospital, Fridley
  • и још 6
Тражи се учесникФаза 3
Узраст 18 и старији · Мушкарци · Ажурирано 8. 10. 2026. · NCT03678025

FOG-001 in Locally Advanced or Metastatic Solid Tumors

  • M Health Fairview University of Minnesota Medical Center, Minneapolis
  • Mayo Clinic, Rochester
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 7. 10. 2026. · NCT05919264

A Study of GSK5458514 Administered Alone or In Combination With Other Anti-Cancer Agents in Participants With Prostate Cancer

  • GSK Investigational Site, Rochester
Тражи се учесникФаза 1/2
Узраст 18 и старији · Мушкарци · Ажурирано 5. 10. 2026. · NCT06990880

Phase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate Cancer

  • M Health Fairview Clinics and Surgery Center, Minneapolis
Тражи се учесникФаза 1
Узраст 18 и старији · Мушкарци · Ажурирано 25. 9. 2026. · NCT06801236

Study of PSMA-targeted Therapy and Androgen Receptor Suppression in Low-volume Metastatic ProstatE Cancer: SPARKLE Trial

  • Mayo Clinic in Rochester, Rochester
Тражи се учесникФаза 2
Узраст 18 и старији · Мушкарци · Ажурирано 18. 9. 2026. · NCT07650240

Carboplatin or Olaparib for BRcA Deficient Prostate Cancer

  • Minneapolis VA Health Care System, Minneapolis, MN, Minneapolis
Тражи се учесникФаза 2
Узраст 18 и старији · Мушкарци · Ажурирано 17. 9. 2026. · NCT04038502

Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy

  • Mayo Clinic- Rochester, Rochester
Тражи се учесникФаза 3
Узраст 18 и старији · Мушкарци · Ажурирано 11. 9. 2026. · NCT06056830

A Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone Acetate or Darolutamide

  • Masonic Cancer Center, Minneapolis
Тражи се учесникФаза 2
Узраст 18 и старији · Мушкарци · Ажурирано 21. 8. 2026. · NCT06844383

Water Vapor Ablation for Prostate Cancer: Long-Term Registry

  • Minnesota Urology, Woodbury
Тражи се учесникОпсервациона студија
Сви узрасти · Мушкарци · Ажурирано 18. 8. 2026. · NCT07455058

MRI-guided Transurethral Urethral Ultrasound Ablation for the Treatment of Low to Intermediate Grade Prostate Cancer

  • Mayo Clinic in Rochester, Rochester
Тражи се учесник
Узраст од 45 до 80 · Мушкарци · Ажурирано 22. 7. 2026. · NCT05438563

Stereotactic Body Radiation Therapy Plus Immediate or Delayed Androgen Receptor Pathway Inhibitor and Androgen Deprivation Therapy or Salvage Radiation Therapy for the Treatment of Prostate Cancer, DIVINE Trial

  • Mayo Clinic in Rochester, Rochester
Тражи се учесникФаза 2
Узраст 18 и старији · Мушкарци · Ажурирано 20. 7. 2026. · NCT06378866

Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response

  • Riverwood Healthcare Center, Aitkin
  • Essentia Health - Baxter Clinic, Baxter
  • Essentia Health Saint Joseph's Medical Center, Brainerd
  • и још 18
Тражи се учесникФаза 3
Узраст 18 и старији · Мушкарци · Ажурирано 14. 7. 2026. · NCT06592924

Study of ORIC-944 in Patients With Metastatic Prostate Cancer

  • Minnesota Oncology Hematology, Minneapolis
Тражи се учесникФаза 1
Узраст 18 и старији · Мушкарци · Ажурирано 9. 7. 2026. · NCT05413421

Integrated Cancer Repository for Cancer Research

  • Riverwood Healthcare Center, Aitkin
  • Essentia Health-St. Joseph's Medical Center, Brainerd
  • Essentia Health - Duluth Clinic, Duluth
  • и још 2
Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
Узраст од 19 до 110 · Оба пола · Ажурирано 29. 6. 2026. · NCT02012699

Breathing Practice for Brain and Mental Health in Cancer and Neurodegenerative Diseases

  • Mayo Clinic in Rochester, Rochester
Тражи се учесникЗдраве особе су добродошле
Узраст од 18 до 85 · Оба пола · Ажурирано 10. 6. 2026. · NCT06788886

Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer

  • Mayo Clinic Rochester, Rochester
Тражи се учесникФаза 4
Узраст од 18 до 100 · Мушкарци · Ажурирано 4. 6. 2026. · NCT05803941

Axelopran for Advanced Cancer in Patients Receiving Opioids

  • HealthPartners Frauenshuh Cancer Research Center, Saint Louis Park
  • HealthPartners Cancer Center at Regions Hospital, Saint Paul
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 5. 5. 2026. · NCT07354919

Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.